Forum Topic News
  • Conversation: Bayer, Orion drug shows strong results in prostate cancer

    • October 24, 2018 4:48 PM BST
    • Bayer, Orion drug shows strong results in prostate cancer

      Bayer and Orion's darolutamide, a novel oral androgen receptor antagonist for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC), has met its primary endpoint in the ARAMIS phase III clinical trial, shwoing that the drug significantly extended metastasis-free survival compared to placebo. The safety profile and the tolerability of darolutamide observed in the ARAMIS trial were consistent with previously published data on darolutamide.
      Read more: http://www.pharmatimes.com/news/bayer,_orion_drug_shows_strong_results_in_prostate_cancer_1256853

Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč